Rebetron (interferon alfa-2b / ribavirin) Drug Interactions
A total of 228 drugs (724 brand and generic names) are known to interact with Rebetron (interferon alfa-2b / ribavirin).
- 28 major drug interactions (109 brand and generic names)
- 195 moderate drug interactions (597 brand and generic names)
- 5 minor drug interactions (18 brand and generic names)
Check for interactions with Rebetron (interferon alfa-2b / ribavirin)
Common medications checked in combination with Rebetron (interferon alfa-2b / ribavirin)
- Bayer Aspirin with Heart Advantage (aspirin)
- Cholestyramine Light (cholestyramine)
- Coumadin (warfarin)
- Dilacor XR (diltiazem)
- eszopiclone
- Heparin Lock Flush (heparin flush)
- Invega (paliperidone)
- Januvia (sitagliptin)
- Lexapro (escitalopram)
- Luvox (fluvoxamine)
- PegIntron (peginterferon alfa-2b)
- Poly CS (brompheniramine / codeine / phenylpropanolamine)
- PosiFlush (heparin flush)
- Prevacid NapraPAC 500 (lansoprazole / naproxen)
- Prinzide (hydrochlorothiazide / lisinopril)
- Strattera (atomoxetine)
- Thalomid (thalidomide)
- Vitamin C (ascorbic acid)
- Xanax XR (alprazolam)
- zolpidem
Rebetron (interferon alfa-2b / ribavirin) alcohol/food Interactions
There is 1 alcohol/food interaction with Rebetron (interferon alfa-2b / ribavirin)
Rebetron (interferon alfa-2b / ribavirin) disease Interactions
There are 14 disease interactions with Rebetron (interferon alfa-2b / ribavirin) which include:
- Renal Dysfunction
- Autoimmune Diseases
- Hepatic Dysfunction
- Cardiac Disease
- Cns Dysfunction
- Depression
- Thyroid Dysfunction
- Anemia
- Pulmonary Deterioration
- Renal Dysfunction
- Colitis
- Diabetes Mellitus
- Myelosuppression
- Peripheral Neuropathy
Drug Interaction Classification
The classifications below are a general guideline only. It is difficult to determine the relevance of a particular drug interaction to any individual given the large number of variables.
| Major | Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. |
| Moderate | Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. |
| Minor | Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. |
Do not stop taking any medications without consulting your healthcare provider.
Disclaimer: Every effort has been made to ensure that the information provided by Multum is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. Multum's information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill, knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2017 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.
